Eisai, Biogen (BIIB) Alzheimer drug granted FDA accelerated approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 229.93 +1.03 (0.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.90 | 52 Week High | $333.65 | |||
| Open | $228.99 | 52 Week Low | $223.02 | |||
| Day High | $233.90 | P/E | 29.44 | |||
| Day Low | $228.00 | EPS | $7.81 | |||
| Volume | 276,416 | |||||
